Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,519,446
-
Number of holders
-
355
-
Total 13F shares, excl. options
-
140,609,143
-
Shares change
-
-1,439,110
-
Total reported value, excl. options
-
$6,095,939,090
-
Value change
-
-$80,597,812
-
Put/Call ratio
-
54%
-
Number of buys
-
166
-
Number of sells
-
174
-
Price
-
$43.35
Institutional Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q1 2024
As of 31 Mar 2024 IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) had 437 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 140,609,143 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock Inc., Bellevue Group AG, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, STATE STREET CORP, PICTET ASSET MANAGEMENT Holding SA, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 437 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.